• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of advisory committee members participating in meetings in the month who were granted waivers

FY 2012 Target: Less than 11.5%

Dictionary: When FDA determines that an advisory committee member has a financial conflict of interest, the agency may grant a waiver that allows the member to participate in an advisory committee meeting if certain criteria and policies are met. In general, FDA may grant a waiver if the member's expertise is considered essential to the committee’s discussions and recommendations. FDA must also take into consideration a cap on the number of waivers that can be granted each year. FDA searches for experts who have the necessary expertise without conflicts of interest; yet, in some cases, many of the top authorities in specialized scientific fields may have a conflict of interest. When FDA grants a waiver, the financial interests associated with the waiver are posted on FDA’s website along with the reasons for granting the waiver.

Information is current as of September 30, 2013.

Fiscal Year - 2012

Skip graphic and jump to text data

FY 2012 Target: Less than 11.5%

TimeTargetPercent Granted Waivers
Oct 201111.50
Nov 201111.50
Dec 201111.50
Jan 201211.50
Feb 201211.50
Mar 201211.57
Apr 201211.50
May 201211.52
Jun 201211.51
Jul 201211.50
Aug 201211.50
Sep 201211.50

FY 2012 Overall: 1%

Total number of advisory committee members participating in meetings in the month who were granted waivers

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetWaivers Granted
Oct 2011N/A0
Nov 2011N/A0
Dec 2011N/A0
Jan 2012N/A0
Feb 2012N/A0
Mar 2012N/A9
Apr 2012N/A0
May 2012N/A4
Jun 2012N/A1
Jul 2012N/A0
Aug 2012N/A0
Sep 2012N/A0

FY 2012 Total: 14

Total number of advisory committee members participating in meetings in the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetCommittee Members
Oct 2011N/A54
Nov 2011N/A178
Dec 2011N/A153
Jan 2012N/A82
Feb 2012N/A140
Mar 2012N/A137
Apr 2012N/A94
May 2012N/A195
Jun 2012N/A94
Jul 2012N/A46
Aug 2012N/A33
Sep 2012N/A122

FY 2012 Total: 1,328

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.